Genome-editing Company Caribou Biosciences Doses First Patient
First allogeneic CAR-T cell therapy with a PD-1 knockout in clinical studies Initial data from trial expected in 2022 Caribou Biosciences, Inc., a leading clinical-stage CRISPR...
Tag : genome sequencing
Genome-editing Focused Life Edit Therapeutics Forms New SAB
Life Edit, an ElevateBio portfolio company, to collaborate with expert scientific advisors to maximize potential of genome-editing platform including novel RNA-guided nucleases and base editors...
Genomic Diagnostics Company Veracyte Announces Key Leadership Hires
Rob Brainin Named Executive Vice President and Chief Business Officer;Bill Zondler Appointed Senior Vice President and Chief Information Officer Veracyte, Inc. (Nasdaq: VCYT), a global genomic...
Verge Genomics Announces Three-Year Collaboration With Lilly
– Verge to Receive Up to $25M in Upfront, Equity Investment and Potential Near-Term Payments, with Additional Milestone Value of $694M and Potential Downstream Royalties – Collaboration...
Verge Genomics Presents Preclinical Data Supporting Oral Antiviral
Verge Genomics, a biotech company that has created an industry leading all-in-human, artificial-intelligence-powered drug discovery and development platform focused on therapies for serious genetic diseases,...
Skin Genomics Platform DermTech Announces New Appointment
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the appointment of Monica Tellado, Senior Vice...
Genomic Amplification Tech Developer BioSkryb Welcomes Gary Harton
Dr. Harton to lead the translation of BioSkryb’s Primary Template-directed Amplification (PTA) technology into breakthrough diagnostic applications for targeted indications, including cancer and neurological disorders...
Genomic Diagnostics Company Veracyte Strengthens Medical Team
Veracyte (Nasdaq: VCYT), a global genomic diagnostics company, today announced key appointments that expand and further strengthen the company’s medical team. William A. Bulman, M.D. and...
Genomic Testing Cooperative Collaborates with Elevation Oncology
Genomic Testing Cooperative, a first-in-class diagnostic company based on a cooperative business model (Co-Op) using the most recent advances in NGS technology, announced today a...
ERS Genomics and Nippon Gene Sign CRISPR/Cas9 License Agreement
License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual...